Adherium Ltd
Research Adherium Ltd (ADR) on Bullrun: market cap AUD 5.49M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerADR
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 5.49M
- Financial periodFY2025
Valuation Snapshot
latest market cap is AUD 5.49M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.01 | n/a | n/a | n/a |
| FY2024 | AUD 840.98K | -AUD 10.22M | -AUD 10.61M | 31.8% | -0.02 | AUD 6.20M | AUD 93.21K | AUD 6.48M |
| FY2023 | AUD 3.20M | -AUD 9.86M | -AUD 9.32M | 79.0% | -0.02 | AUD 9.08M | AUD 44.00K | AUD 9.21M |
| FY2022 | AUD 529.00K | -AUD 11.22M | -AUD 9.89M | 60.9% | -0.05 | AUD 5.28M | AUD 85.00K | AUD 4.36M |
| FY2021 | AUD 401.00K | -AUD 15.04M | -AUD 11.30M | -6.2% | n/a | AUD 15.18M | n/a | AUD 14.04M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | AUD 5.49M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Adherium Ltd
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Adherium Ltd's market cap?
Adherium Ltd's market capitalization is AUD 5.49M.
What does Adherium Ltd do?
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution. The company was founded in 2001 and is based in Melbourne, Australia.